Background. Two major hypotheses have been proposed to explain catecholamine supersensitivity after myocardial denervation, but neither sufficiently explains certain features of the phenomenon.
Conclusions. We have demonstrated that substantial, long-term myocardial adrenergic denervation is possible using 6-OHDA. Denervation supersensitivity in this model does not depend on enhanced cAMP stimulation but rather depends on postreceptor elements in the ,lAR-responsive pathway that may be independent of G,-activated adenylyl cyclase activity. In this model of adrenergic denervation supersensitivity, P-receptors, through GQ, may be linked to an alternative effector that drives heart rate responsiveness. (Circulation 1992;85:666-679) T wo hypotheses have been proposed to explain catecholamine supersensitivity after myocardial denervation. The presynaptic hypothesis proposes that supersensitivity is due to absence of uptake-1 clearance, which depends on intact adrenergic nerves.' Although this may account for supersensitivity to norepinephrine, it does not explain supersensitivity to isoproterenol, which does not depend on uptake-1 clearance. The postsynaptic hypothesis proposes that supersensitivity may involve changes in the 3-adrenergic receptor (/3AR)-responsive adenylyl cyclase pathway, such as BAR upregulation, but myocardium from transplanted (denervated) human hearts does not show 8AR upregulation,2 and no studies have shown increased fAR-mediated adenylyl cyclase activation after myocardial denervation; therefore, this hypothesis, although appealing, has not been proven.
Previous studies have used total cardiac denervation (sympathetic and parasympathetic) to study this phenomenon.1"2 We used 6-hydroxydopamine (6- OHDA) to induce selective, nonsurgical myocardial adrenergic denervation, avoiding the potentially confounding influences of thoracotomy and parasympathetic denervation. Because surgical myocardial denervation has limitations (i.e., requires thoracotomy and can result in high perioperative mortality rates, concomitant parasympathetic denervation, and nerve regrowth), a nonsurgical method of denervation is desirable.
A potential problem with 6-OHDA-induced denervation is nerve regrowth. For example, 2 hours after injecting adult mice with 6-OHDA, myocardial norepinephrine concentrations were decreased 95%; by 8 weeks, however, myocardial norepinephrine concentration returned to normal, suggesting regeneration of adrenergic nerve terminals. 3 In contrast, when 6 -OHDA was given repeatedly during the first 10 days of life to newborn rats, myocardial norepinephrine depletion was substantial (85%) 15 weeks later, suggesting that chronic myocardial adrenergic denervation is possible if 6-OHDA is given when adrenergic neural pathways are still forming.4 Thus, our study had two goals: to develop a model of long-term, nonsurgical myocardial adrenergic denervation, and to define the relations between myocardial 3AR number, physiological responsiveness, and postreceptor elements resulting from myocardial adrenergic denervation.
To achieve these goals, we administered 6-OHDA to newborn pigs and studied the pigs 14 6 -OHDA is metabolized rapidly; it has been shown that 24 hours after intravenous injection of [3H]-6-OHDA to rats, no [3H]-amines were found in heart or spleen5; therefore, toxicity related to persistent drug is not likely. All pigs remained with their mother and were weaned at the usual time (8-10 weeks). Five pigs survived and underwent pharmacological and physiological testing at 14-15 weeks and were killed at 16 weeks. These pigs fed vigorously and were developmentally normal.
Controls were 10 weight-matched pigs (control, 14±3 kg; 6-OHDA, 13±3 kg; p=NS). Five were killed, and myocardial samples were used for biochemical studies; five underwent identical pharmacological and exercise tests as the experimental group. Experimental and control animals were housed in identical quarters and received identical amounts of human contact.
Isoproterenol-Stimulated Chronotropic Response
After placement of venous and arterial catheters (neck incision, aseptic) and full recovery from surgery (minimum 2 days), animals underwent pharmacological testing using (-)isoproterenol.6 Tests were conducted in early morning hours in a quiet, dark laboratory (21°C). Response to isoproterenol was assessed by graded bolus injections of (-)isoproterenol (10-500 jug/kg i.v.) and recording heart rate until there was no further increase (usually 30 seconds). At low doses, the 12-second period showing the largest increase in heart rate was taken as the maximal response. This interval always included at least one full respiratory cycle. At higher doses, respiratory variation in heart rate was not present; therefore, the shortest RR interval was taken as the maximal response. Heart rate returned to baseline between each dose of isoproterenol. Injections were given until there was less than 5% increase in heart rate: The preceding dose was chosen as the one that caused a maximal response. The order of delivery of doses of isoproterenol does not affect the relation between dose and response by using this protocol. The relation between change in heart rate and the logarithm of the dose of isoproterenol (micrograms per kilogram) was examined by linear regression analysis. Two or three tests conducted on separate days were combined into a single linear regression in each animal. Correlation coefficients (r) ranged from 0.92 to 0.98 (mean, 0.95+0.02). The dose of (-)isoproterenol yielding ED50 was calculated from the linear regression equation.
In previous studies of mature pigs, we used atropine pretreatment to block reflex vagal withdrawal during isoproterenol testing67 because the intervention (exercise training) was expected to alter vagal tone. In the present study, we found that atropine (0.075 mg/kg) raised basal heart rates in these young animals to a degree that significantly limited the range at which the isoproterenol dose-response relation could be examined (171 ± 15 beats per minute). In addition, we have found that after atropine administration, heart rate begins to return toward base- 15 Experiments were conducted to establish that ,-receptors were not lost to the supernatant. When LV membranes were prepared (as above), K+-pNPPase activity, a marker for sarcolemmal membrane, was negligible in the supernatant. We therefore concluded that receptors, if present in the supernatant, must be unassociated with sarcolemmal membrane fragments. To detect solubilized receptors, we dialyzed 10 ml supernatant from a 45,000g centrifugation with 1.0 1 potassium-deficient Tris buffer overnight at 4°C to reduce KCl concentration (to prevent interference with the receptor-radioligand interaction). Supernatants (0.3 mg/ml) then were used in saturation isotherm experiments (n =2; LV from control and 6-OHDA-treated animals). GF/C filter paper was pretreated with 2% polyethylenimine to trap solubilized receptors. 16 There was no specifically bound ICYP in the supernatant fraction of control or 6-OHDA-treated animals. Thus, we believe that data obtained from saturation isotherms conducted on the membrane preparation used accounts for all of the P-receptors.
Adenylyl Cyclase Assays
Methods were modified from those of Salomon.17 Adenylyl cyclase activity was determined in a final volume of 100 ,ul, and the assay mixture included final concentrations of 0.5 mM ATP, 5 mM creatine phosphate, 50 U/ml creatine phosphokinase, 0.1 mM cAMP, 10 mM HEPES buffer (pH 7.4), 2.5 mM MgCl2, 0.25 mM EDTA, and 0.74 ,uM [a-32P]-ATP (800,000 cpm). The following agents were used to stimulate cAMP production (final concentrations are given): manganese (10 mM), Gpp[NH]p (100 ,uM), isoproterenol (10 ,uM) , and NaF (10 mM). Appropriate concentrations of Gpp(NH)p and other stimulants were determined in preliminary studies. To clarify the efficiency of G,-dependent stimulation of adenylyl cyclase, Gpp(NH)p was used in increasing doses and cAMP production was measured. To clarify the efficiency of OAR-dependent stimulation of adenylyl cyclase, (-)isoproterenol was used in increasing doses (with 100 ,M GTP) and cAMP production was measured.
Reactions were initiated by adding 120-140 gg of myocardial membrane homogenate to ice-cold reactants and incubating at 37°C for 15 minutes. We found that cAMP production under these conditions was linear with respect to time and protein concentration and that isobutyl methylxanthine or adenosine deaminase (or both) had no effect on basal or maximally stimulated cAMP production. Reactions were terminated by placing tubes in an ice-cold bath and adding 100 ,ul stopping solution containing 40 mM ATP, 1.4 mM cAMP, [3H]-cAMP (7,000 cpm), and 50 mM Tris-HCl (pH 7.5); Na dodecyl S04 (2%) then was added to each tube, and tubes were heated to 100°C for 3 minutes. Volumes were then brought to 1 ml by adding 800 ,ul water, and cAMP was fractionated using Dowex-alumina sequential column chromatography. Recovery was 75-92% by these methods, and replicate variation was less than 10%.
Experiments were conducted to establish that adenylyl cyclase activity was not lost in the supernatant of a 45,000g centrifugation. We found that forskolinstimulated cAMP production was negligible in the supernatant of a 45,000g centrifugation prepared from LV membranes (supernatant, 18 pmol/mg/min; pellet, 541 pmol/mg/min; n=2). NaF stimulation was used to assess the presence of G, and catalyst in the supernatant. Less than 2% of cAMP produced was found in the supernatant (control, 4+2 pmol/mg/ min; 6-OHDA, 5+2 pmol/mg/min; p=NS; n=4 for both groups). These data exclude the possibility that reduced adenylyl cyclase activity was due to loss of adenylyl cyclase activity in the supernatant.
To determine the effects of endogenous catecholamines on adenylyl cyclase activity, we performed experiments on LV homogenates from seven control pigs, measuring the impact of 1.0 ,uM propranolol on basal, fluoride-stimulated, and Gpp(NH)p-stimulated cAMP production. Blocking the effects of endogenous catecholamines with propranolol did not alter basal (no propranolol, 57±12 pmol/mg/min; propranolol, 60±17 pmol/mg/min), fluoride-stimulated (no propranolol, 189+48 pmol/mg/min; propranolol, 181±61 pmol/mg/min), or Gpp(NH)p-stimulated adenylyl cyclase activity (no propranolol, 135 ±44 pmol/mg/min; propranolol, 134±+41 pmol/ mg/min). Thus, differences in adenylyl cyclase activity are not likely to result from differences in endogenous catecholamine concentrations.
Quantification of G,
We modified a reconstitution assay for use with porcine myocardial membranes. 18 The capacity of a cholate extract of myocardial membrane homogenate to reconstitute G,-mediated production of cAMP in membranes of G,-deficient (cyc-) murine S49 lymphoma cells served as a functional assay for G,. Cyccells (strain 94.15.1) were grown at 37°C in Dulbecco's modified Eagle's medium containing 25 mM Na HEPES (pH 7.4) and 10% heat-inactivated horse serum. Plasma membranes were prepared after the methods of Ross et a119 by using a nitrogen cavitation apparatus to lyse cells by rapid decompression after equilibration for 10 minutes with N2 at 450 psi at 4°C. Cyc-membranes were suspended (3 mg/ml) in buffer (20 mM Na HEPES, pH 8.0), 2 mM MgCl2, and 1 mM EDTA. The preparation then was stored at -700C.
Cardiac membrane homogenates (SAN and RA) were suspended (3 mg/ml) in Tris buffer and solubilized in 1% Na cholate for 1 hour at 4°C. The supernatant from a 45,000g spin (at 4°C for 30 minutes) was heated at 30°C for 10 minutes to inactivate solubilized catalytic subunit of adenylyl cyclase. This extract was then diluted in 0.1% Lubrol PX (in the same buffer) to stabilize GQ, and 15 ,ul of extract (or serially diluted extract) was then added to FIGURE 1 Gs-dependent stimulation of adenylyl cyclase.
Data Analysis
Data are expressed as mean±+1 SD. Comparisons of group means are made using t test for unpaired data. The null hypothesis was considered unlikely when p <0.10 and rejected whenp <0.05 (two-tailed). The Pearson product-moment correlation coefficient (r) is reported as a measure of the strength of association between change in heart rate and logarithm of dose of isoproterenol determined by linear regression analyses. Saturation isotherm experiments underwent Scatchard analysis, and competition binding experiments were analyzed by nonlinear regression (Graphpad, Harvey Motulsky, UCSD). F ratios were used to test whether one-or two-component curves better fit the data, and when equivalent, the simpler model was selected.
Results

Tissue Catecholamines
Sixteen weeks after 6-OHDA treatment of neonatal pigs, histological analyses of sections of RA and LV stained with glyoxylic acid, which causes fluorescence of biogenic amines, showed that denervation was distributed evenly across the LV wall from endocardium to epicardium. Much of the histofluorescence remaining in RA of 6-OHDA-treated animals was associated with vascular structures (Figure 1 ). Radioenzymatic measurements of myocardial norepinephrine content (Figure 2 ) documented substantial denervation, with an 81% reduction in SAN norepinephrine content (control, 7,117+927 pg/mg; 6-OHDA, 1,329+303 pg/mg; p<0.001), a 79% reduction in RA norepinephrine (control, 4,294+621 pg/mg; 6-OHDA, 918+272 pg/mg; p<0.001), and an 83% reduction in LV norepinephrine (control, 1,471±574 pg/mg; 6-OHDA, 252+±213 pg/mg;p<0.01). Myocardial epinephrine was unchanged by 6-OHDA treatment in SAN (control, 117+64 pg/mg; 6-OHDA, 95±44 pg/mg; p=NS), RA (control, 51±39 pg/mg; 6-OHDA, 88+ 139 pg/mg; p=NS), and LV (control, 52±25 pg/mg; 6-OHDA, 44±73 pg/mg; p=NS).
Adrenal epinephrine (control, 335 ± 145 ng/mg; 6-OHDA, 377±132 ng/mg; p=NS) and norepinephrine (control, 309±215 ng/mg; 6-OHDA, 365+154 ng/mg;p=NS) were unaltered by 6-OHDA treatment.
Isoproterenol-Stimulated Chronotropic Response Figure 3 shows results of dose-response studies examining the ability of graded bolus doses of isoproterenol to increase heart rate. Basal heart rate was unchanged by 6-OHDA treatment (control, 117±14 beats per minute; 6-OHDA, 132±13 beats per minute; p=0.17), but maximal isoproterenol-stimulated heart rate was decreased somewhat (control, 267±+ 6 beats per minute; 6-OHDA, 245+±12 beats per minute; p<0.05). Isoproterenol ED50 for heart rate change was decreased by 50% after denervation (control, 0.08±+0.03 gg/kg; 6-OHDA, 0.04±0.01 ,(glkg;p=0.01; Figure 3 ). The threshold dose, the minimal dose of isoproterenol required for an effect on heart rate, was determined from the dose-response data (X intercept). This value was 50% reduced in animals treated with 6-OHDA (control, 21±5 ng/kg; 6-OHDA, 10±2 ng/kg; p =0.04), thus confirming, in a manner independent of maximal response, that heart rate response to isoproterenol stimulation was increased.
Treadmill Exercise Testing
Heart rate response to graded treadmill exercise is shown in Figure 4 . Heart rates while standing on the treadmill, in anticipation of running, were similar (control, 148±22 beats per minute; 6-OHDA, 147± 18 beats per minute; p=NS), as were maximal exercise heart rates (control, 306±18 beats per minute; 6-OHDA, 316±14 beats per minute;p=NS). Maximal work rates were similar (control, 218±34 KPM/min; 6-OHDA, 243±57 KPM/min; p=NS). However, heart rate responses during graded submaximal exercise were quite different. For example, during stage 1, at heart rates indicating complete parasympathetic withdrawal,22 heart rate was much higher in 6-OHDA-treated animals (control, 209±16 beats per minute; 6-OHDA, 257±26 beats per minute; p=0.01; Figure 4 ). Increased heart rate response in 6-OHDA-treated animals was observed through the first several stages of exercise but became less apparent at higher work rates because maximal heart rate was unchanged. 
Plasma Catecholamine Measurements
Basal plasma epinephrine (control, 143 ±75 pg/ml; 6-OHDA, 133+37 pg/ml) and norepinephrine (control, 285+±55 pg/ml; 6-OHDA, 269±41 pg/ml) were unchanged [14] [15] [16] pg/ml; 6-OHDA, 9,510±f-3,776 pg/ml; p=0.06) were reduced at peak exercise (Figure 4 , inset).
/3-Adrenergic Receptor Binding Studies Figure 5 shows the results of saturation isotherm experiments; ,BAR number was decreased by 6 Adenylyl Cyclase Assays Basal (unstimulated) adenylyl cyclase activity was lower in denervated animals (control, 89±17 pmol/ mg/min; 6-OHDA, 30±12 pmol/mg/min). Adenylyl cyclase activity is therefore reported as net increase in stimulation (basal subtracted) to adjust for differ- Gpp(NH)p-stimulated adenylyl cyclase activity was diminished markedly through a wide range of Gpp-(NH)p concentrations ( Figure 7) . Similarly, isoproterenol-stimulated adenylyl cyclase activity was diminished markedly through a wide range of isoproterenol concentrations (Figure 8 ). In addition to marked diminution of Gs-dependent activation, the EC50 for Gpp(NH)p-stimulated cAMP produc- ished ,3AR-dependent activity, the EC50 for isoproterenol-stimulated cAMP production was preserved (control, 0.3+0.3 ,uM; 6-OHDA, 0.5+±0.5 ,M; p=NS), suggesting preserved receptor-G, coupling.
These data strongly suggest decreased receptor-dependent and G,-dependent adenylyl cyclase activation through a wide range of physiologically relevant concentrations of agonist.
Quantification of G,
To see if diminution in adenylyl cyclase activity was the result of diminished G,, we performed reconstitution assays by using cholate extracts (Gs rich) from SAN ( Figure 9) min; p=NS). Differences in absolute cAMP production between SAN and RA in reconstitution assays reflect differences in catalytic subunit content of cyccells that can vary 10-to 20-fold.18
Assessment of Gi
To see if diminution in adenylyl cyclase activity in denervated myocardium was the result of increased Gi, we performed pertussis toxin-mediated ADP ribosylation studies to assess Gi in sarcolemmal membranes from SAN (Figure 9, inset) and LV. We found that pertussis toxin-catalyzed incorporation of [32p] into sarcolemmal membranes was reduced nearly 50% after denervation in SAN (control, 2,310+579 fmol/mg; 6-OHDA, 1,204+354 fmol/mg;p<0.01) and in LV (control, 1,694 +481 fmol/mg; 6-OHDA, 872± 292 fmol/mg; p<0.02).
Pertussis toxin pretreatment of atrial tissue, performed to inactivate Gi, showed that 6-OHDAtreated animals still showed a 42% decrease in Gpp(NH)p-stimulated cAMP generation (p=0.02, n=4 for both groups). These data suggest that depressed cAMP production was not due to inhibition of adenylyl cyclase by Gi.
Discussion There are four principal findings of this work. First, 6-OHDA, when given to newborn pigs, results in substantial myocardial adrenergic denervation that persists for at least 16 weeks. Second, myocardial adrenergic denervation is associated with noncoordinate changes in myocardial flAR number and physiological responsiveness. Thus, after denervation, the heart appears to have a more efficient signal transduction mechanism, resulting in an enhanced response to flAR stimulation of a reduced number of ,8-adrenergic receptors. Denervation supersensitivity, in this model, depends on postreceptor elements in the ,BAR responsive pathway. Third, a factor that may contribute to denervation supersensitivity is enhanced interaction of fAR and cardiac GQ, as reflected by increased high-affinity binding after adrenergic denervation. The implications of these findings are that receptor number and physiological responsiveness may not be coordinately regulated in the heart after adrenergic denervation and that postreceptor elements in the fl-receptor responsive pathway may represent a key mechanism for maintaining effective physiological responsiveness. And finally, the finding with the most important implications is that increased ,BAR-dependent stimulation of heart rate occurs independently of adenylyl cyclase stimulation, suggesting that fl-receptors, through GQ, may be linked with an alternative effector that drives heart rate responsiveness.
Increased physiological responsiveness to flAR stimulation after 6-OHDA treatment is supported by five observations. First, isoproterenol ED50 for heart rate was decreased by 50% (Figure 3) . The Vatner and colleagues,1 using total cardiac denervation (surgical) in dogs, found a 50% decrease in norepinephrine ED50 for heart rate, but unlike our study, they found a 50% increase rather than a decrease in myocardial fAR number. Differences between their study and ours may be due to a species difference, to the influence of parasympathetic denervation in their model (vagal fibers are unaffected by 6-OHDA), or to an effect of 6-OHDA on ,BAR development or regulation when administered to immature animals.
Myocardial j3AR number does not change in hearts of human transplant recipients, despite complete cardiac denervation. Indeed, two recent reports show a tendency for ,BAR downregulation in the transplanted heart.2,24 We had speculated that failure of fl-receptors to upregulate in cardiac transplantation may reflect the influence of combined preganglionic parasympathetic and postganglionic sympathetic denervation. However, we have shown that denervation with 6-OHDA, which leaves preganglionic parasympathetic nerves intact, is associated with myocardial f3AR downregulation. Therefore, preganglionic parasympathetic innervation may not be an important determinant of ,BAR number after adrenergic denervation of the heart.
Isoproterenol, by interacting with fl-receptors in the sinoatrial node, induces tachycardia. However, isoproterenol decreases arterial blood pressure and widens pulse pressure, and therefore can activate baroreceptor reflexes, which may, independently of direct interaction with SAN fl-receptors, influence heart rate. Altered vagal tone at the SAN is an efferent component in this reflex. Cardiac transplantation and complete surgical denervation interrupt preganglionic parasympathetic nerves, thereby introducing a potentially confounding element into data obtained from isoproterenol-stimulated heart rate studies, especially when compared with subjects with intact parasympathetic nerves. This may explain why the effects of complete cardiac denervation on heart rate responses to isoproterenol have been reported to increase1l25 or not change.2,24 Our study circumvents these problems: Parasympathetic innervation is not altered by 6-OHDA,26 the afferent components that determine baroreceptor-mediated reflex control of vagal tone (arterial blood pressure and pulse pressure) were not altered, and myocardial muscarinic cholinergic receptor has been reported to be unchanged. 26 We believe that the demonstration of a 50% reduction in isoproterenol ED50 for heart rate change reflects enhanced SAN signal transduction independent of altered reflex modulation.
A study of human cardiac transplant patients (total cardiac denervation) showed increased heart rate responsiveness to epinephrine but not to isoproterenol.2 This report and the previous report by Vatner et all proposed that denervation supersensitivity results in part from decreased neural catecholamine uptake, thereby resulting in prolonged activation of PAR by exogenous norepinephrine or epinephrine. We found that sensitivity to isoproterenol and plasma catecholamines (exercise) were increased to similar degrees. Because isoproterenol clearance does not depend on neural uptake,27 the data suggest postsynaptic denervation supersensitivity.
The proportion of high-affinity binding sites, determined by competitive binding with (-)isoproterenol in the absence of GTP, was increased 2.5-fold in both RA and LV membranes after denervation (Table 1). A higher proportion of high-affinity binding sites implies tighter coupling of the flAR with G, in denervated myocardium; this may be important mechanistically in denervation supersensitivity.
Competitive radioligand binding studies using selective 8l1-receptor antagonists ( different species and with the use of different methods for denervation, are very similar to our own and suggest that our findings may have broad application.
An obvious concern regarding the diminution of adenylyl cyclase activity in myocardial membranes from denervated pigs was whether increased Gi might be inhibiting full expression of cAMP production. However, we found a 50% decrease in pertussis toxin substrate in SAN and LV membranes after denervation and decreased GQ-dependent cAMP production after inactivation of Gi by pretreatment with pertussis toxin. A 50% decrease in adenylyl cyclase stimulation despite a 50% decrease of Gi underscores our contention that denervation supersensitivity, in this model, does not depend on stimulation of adenylyl cyclase. If G, is activating an alternative effector that regulates heart rate response, decreased Gi would allow enhanced effector stimulation in the 6-OHDAtreated animals, thus contributing to denervation supersensitivity. Such speculation assumes that Gi as well as G, can interact at effectors other than adenylyl cyclase.
Decreased pertussis toxin substrate may have important effects on muscarinic cholinergic receptor signal transduction, a pathway unexamined in the present work. Reduced cardiac Gi may have contributed to elevated basal heart rate and increased heart rate response early during exercise. However, if isoproterenol-stimulated heart rate response results partially from vagal withdrawal at the SAN,25 reduced cardiac Gi and less basal vagal tone would diminish heart rate responsiveness. That denervated animals had increased responsiveness to isoproterenol stimulation despite presumed decreased vagal tone underscores our findings, making the adrenergic denervation supersensitivity all the more impressive.
Although exact molecular mechanisms elude us, the findings of postsynaptic denervation supersensitivity in association with depressed adenylyl cyclase activity are, we believe, convincing. In addition, increased f3AR-Gs coupling and preserved cardiac G, function are provocative observations. It has been demonstrated in isolated cell preparations that G, can stimulate voltage-gated calcium channels independently of adenylyl cyclase.31 Recent work has confirmed that myocardial cell calcium current can be stimulated through 83AR activation of G, independently of adenylyl cyclase32 and that G, can be found closely associated with calcium channels. 33 On the basis of data from these recent studies,31-33 we believe the present data are best explained by a pAR-driven, GQ-mediated but adenylyl cyclase-independent control of heart rate. We speculate that G, Gs may be activating a calcium channel, thereby influencing heart rate responsiveness independently of cAMP production.
